During the universal by SARS-CoV-2 the pregnant women, crowd older than 60 age, lung problems (asthma, COPD), myocardial infarction, brain and nervous system environments, cancer and sure blood disorders, weakened invulnerable system, chronic kind, liver disease, insane health condition, down disease and kids under 5 years are considered a group of risk, even though pregnant girls infected with SARS-COV-2 are mainly asymptomatic or present mild COVID-19 very analogous to non-pregnant women. The aim is review the humanness by COVID-19 in pregnant women in Mexico.Sever severe respiratory disease coronavirus 2 (SARS-CoV-2) is a virus that are more similar to sock coronavirus than human SARS. COVID-19 starts as a pneumonia case with unfamiliar study of animal and origin, The coronavirus affliction 19 is a highly transmittable and pathogenic zealous infection caused by harsh acute respiring syndrome coronavirus 2. Genomic analysis told that SARS-CoV-2 is phylogenetically related to severe severe respiratory disease-like (SARS-like) bat viruses, therefore sock could be the possible basic reservoir. Main manifestations reported in COVID 19: fever, dry cough, asthenia, myalgia, arthralgias, difficulty chills, odynophagia and dyspnea. Anosmia, ageusia, diarrhea, disgorging, nasal congestion and hemoptysis are less average.According to different studies made in Mexico, skilled is no evidence that pregnant women are more naive to severe SARS-CoV-2 contamination. However, they being considered as a population group in danger, it has been shown that equating other comorbidities to a degree pneumonia, asthma, COPD and even the increase in age, they are susceptible to the increase mortality rate and problems in patients afflicted by COVID 19.
Author(s) Details:
Michelle Arias-Morales,
Department
of Research and Technological Development, Teaching and Research Directorate,
Institute of Public Health from Guanajuato State, Mexico and School of
Medicine, Quetzalcoatl University in Irapuato, Mexico.
Edith
Fernanda Villanueva Mendez,
Department
of Research and Technological Development, Teaching and Research Directorate,
Institute of Public Health from Guanajuato State, Mexico and School of
Medicine, Quetzalcoatl University in Irapuato, Mexico.
Luis Ignacio Pérez-Velázquez,
Department of Research and Technological Development, Teaching and
Research Directorate, Institute of Public Health from Guanajuato State, Mexico
and Division of Health Sciences, Campus Leon, University of Guanajuato, Mexico.
Maria de Jesús Gallardo-Luna,
Department of Research and Technological Development, Teaching and
Research Directorate, Institute of Public Health from Guanajuato State, Mexico.
Gilberto Flores-Vargas,
Department
of Research and Technological Development, Teaching and Research Directorate,
Institute of Public Health from Guanajuato State, Mexico.
Efraín
Navarro-Olivos,
Teaching
and Research Directorate, Institute of Public Health from Guanajuato State,
Mexico.
Nicolás Padilla-Raygoza,
Department of Research and Technological Development, Teaching and
Research Directorate, Institute of Public Health from Guanajuato State, Mexico.
Please
see the link here: https://stm.bookpi.org/NRAMMS-V5/article/view/12170
